Updates on Pharmacotherapy for Tumor-related Epilepsy (TRE)

Dates and Times

Start: 4/24/2026 8:00 AM
End: 4/24/2026 9:00 AM

Objectives

1. Understand the interplay between emerging tumor biomarkers and pharmacologic management of TRE patients
2. Review and apply established clinical evidence supporting TRE care, specifically the initiation, maintenance and discontinuation of seizure medications

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.